Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cae Tolman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the American Society of Nephrology : JASN|March 25, 2005
Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical studyCae Tolman, Donald Richardson, Cherry Bartlett, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
Development and exploitation of a clinical decision support system for the management of renal anaemiaEric J Will, Donald Richardson, Cae Tolman, et al.
Journal of Bone and Mineral Metabolism|May 31, 2022
Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney diseaseAkimitsu Miyauchi, Etsuro Hamaya, Kiyoshi Nishi, et al.
Pharmaceutical Medicine|November 5, 2025
Evaluating the MAPA Medical Affairs Competency Framework: Insights from Amgen-Led Pilot Study in Australia, Japan and ChinaRiaz Abbas, Orin Chisholm, Victoria Elegant, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2007
Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemiaRobert M West, Katie Harris, Mark S Gilthorpe, et al.
Journal of Bone and Mineral Metabolism|October 15, 2020
Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trialAkimitsu Miyauchi, Etsuro Hamaya, Wenjing Yang, et al.
Journal of Bone and Mineral Metabolism|June 17, 2026
24-month real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Australia, Taiwan, South Korea, Hong Kong, and SingaporeTang Ching Lau, Dong-Gune Chang, Chung-Hwan Chen, et al.
Journal of Bone and Mineral Metabolism|November 19, 2025
Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-PacificTang Ching Lau, Dong-Gune Chang, Chung-Hwan Chen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|March 25, 2005
Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: a randomized clinical studyCae Tolman, Donald Richardson, Cherry Bartlett, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
Development and exploitation of a clinical decision support system for the management of renal anaemiaEric J Will, Donald Richardson, Cae Tolman, et al.
Journal of Bone and Mineral Metabolism|May 31, 2022
Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney diseaseAkimitsu Miyauchi, Etsuro Hamaya, Kiyoshi Nishi, et al.
Pharmaceutical Medicine|November 5, 2025
Evaluating the MAPA Medical Affairs Competency Framework: Insights from Amgen-Led Pilot Study in Australia, Japan and ChinaRiaz Abbas, Orin Chisholm, Victoria Elegant, et al.
Journal of the American Society of Nephrology : JASN|July 13, 2007
Functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients describes the variability of patient responses in the control of renal anemiaRobert M West, Katie Harris, Mark S Gilthorpe, et al.
Journal of Bone and Mineral Metabolism|October 15, 2020
Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trialAkimitsu Miyauchi, Etsuro Hamaya, Wenjing Yang, et al.
Journal of Bone and Mineral Metabolism|June 17, 2026
24-month real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Australia, Taiwan, South Korea, Hong Kong, and SingaporeTang Ching Lau, Dong-Gune Chang, Chung-Hwan Chen, et al.
Journal of Bone and Mineral Metabolism|November 19, 2025
Real-world persistence and compliance of denosumab versus alendronate among postmenopausal women with osteoporosis in Asia-PacificTang Ching Lau, Dong-Gune Chang, Chung-Hwan Chen, et al.
Pageof 1